Medindia LOGIN REGISTER
Medindia
Advertisement

Reportlinker Adds U.S. Skin Cancer Market

Wednesday, May 11, 2011 General News
Advertisement
NEW YORK, May 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Advertisement

U.S. Skin Cancer Market

http://www.reportlinker.com/p0490652/US-Skin-Cancer-Market.html

This research service analyzes the U.S. skin cancer therapeutics market. Market drivers, restraints and challenges faced by industry participants are analyzed. Revenue forecasts for marketed and U.S. Food and Drug Administration (FDA) filed products are discussed. This research service also includes analysis for current pipeline products and clinical trials as well as strategic recommendations.
Advertisement

Table of Contents

Market Introduction and Segments

Disease Characteristics 12

Skin Cancer Market Segments 13

Melanoma Background 14

NonmelanomaBackground 15

BCC Background 16

SCC Background 17

Epidemiology 18

Risk Factors 19

Staging and Prognosis 20

Staging: Melanoma Skin Cancer 21

Staging: Nonmelanoma Skin Cancer 22

Survival Rates: Melanoma Skin Cancer 23

Patient Outlook

Patient Forecasts of Skin Cancer in the United States 25

Patient Forecasts of Melanoma in the United States 26

Patient Forecasts of BCC in the United States 27

Patient Forecasts of SCC in the United States 28

Industry Challenges 30

Current Therapies 32

Key Trends 34

Market Drivers and Restraints

Market Drivers and Restraints 37

Market Drivers 38

Market Restraints 39

Product Forecasts

Melanoma Market: Forecasting Assumptions 41

Intron-A: Revenue Forecast 42

Ipilimumab: Revenue Forecast 43

Pipeline Analysis

Late-Stage Melanoma Compounds: Clinical Trial Overview 45

Melanoma: U.S. Approval Timeline 46

Melanoma Market: Competitive Analysis 47

Strategic Recommendations 49

Skin Cancer Market: Conclusions 53

Decision Support Database

Total Population 55

Number of Biotechnology Companies 58

About Frost & Sullivan

Who is Frost & Sullivan 62

What Makes Us Unique 63

T.E.A.M. Methodology 64

Global Perspective 65

List of Figures

Skin Cancer Market: Patient Forecasts (U.S.), 2007-2017 25

Skin Cancer Market: Melanoma Patient Forecasts (U.S.), 2007-2017 26

Skin Cancer Market: BCC Patient Forecasts (U.S.), 2007-2017 27

Skin Cancer Market: SCC Patient Forecasts (U.S.), 2007-2017 28

Skin Cancer Market: Impact of Top Four Industry Challenges (U.S.), 2011-2017 30

Current Therapies for Melanoma (U.S.), 2010 32

Skin Cancer Market: Market Drivers Ranked in the Order of Impact (U.S.), 2011-2017 38

Skin Cancer Market: Market Restraints Ranked in the Order of Impact (U.S.), 2011-2017 39

Melanoma Market: Forecasting Assumptions (U.S.), 2011 41

Melanoma Market: Intron-A Revenue Forecasts (U.S.), 2007-2017 42

Melanoma Market: IpilimumabRevenue Forecasts (U.S.), 2007-2017 43

Melanoma Market: Clinical Trial Overview (U.S.), 2010 45

Melanoma Market: Competitive Analysis (U.S.), 2010 47

Decision Support Database: Total Population in Million (World), 2004-2014 55

Decision Support Database: Total Number of Biotechnology Companies (World), 2004-2014 58

List of Charts

Skin Cancer Market: Market Drivers and Restraints (U.S.), 2011-2017 37

Melanoma Market: Intron-A Revenue Forecasts (U.S.), 2007-2017 42

Melanoma Market: IpilimumabRevenue Forecasts (U.S.), 2007-2017 43

Melanoma Market: Approval Timeline (U.S.), 2011-2017 46

Skin Cancer Market: Key Stakeholders (U.S.), 2010 49

To order this report:

: U.S. Skin Cancer Market

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close